Stock Traders Purchase High Volume of Put Options on AdaptHealth (NASDAQ:AHCO)

AdaptHealth Corp. (NASDAQ:AHCO) saw some unusual options trading activity on Thursday. Stock investors purchased 41,622 put options on the company. This is an increase of approximately 1,002% compared to the typical volume of 3,777 put options.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on AHCO shares. Canaccord Genuity Group lowered their target price on AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, November 6th. Robert W. Baird lowered their price target on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a research note on Wednesday, November 6th. UBS Group cut their price objective on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research report on Wednesday, November 6th. Royal Bank of Canada decreased their target price on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating for the company in a research report on Tuesday, November 19th. Finally, Truist Financial cut their price target on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, November 15th. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, AdaptHealth presently has a consensus rating of “Buy” and an average target price of $12.40.

Institutional Investors Weigh In On AdaptHealth

A number of hedge funds have recently bought and sold shares of AHCO. Dimensional Fund Advisors LP increased its position in AdaptHealth by 43.9% during the second quarter. Dimensional Fund Advisors LP now owns 2,327,738 shares of the company’s stock worth $23,277,000 after acquiring an additional 710,131 shares during the period. Sei Investments Co. grew its position in AdaptHealth by 27.8% in the 2nd quarter. Sei Investments Co. now owns 262,475 shares of the company’s stock worth $2,625,000 after purchasing an additional 57,018 shares during the last quarter. Bank of Montreal Can increased its holdings in shares of AdaptHealth by 255.9% during the 2nd quarter. Bank of Montreal Can now owns 77,119 shares of the company’s stock worth $773,000 after purchasing an additional 55,448 shares during the period. MBB Public Markets I LLC acquired a new position in shares of AdaptHealth during the second quarter valued at about $142,000. Finally, The Manufacturers Life Insurance Company lifted its stake in shares of AdaptHealth by 8.1% in the second quarter. The Manufacturers Life Insurance Company now owns 39,440 shares of the company’s stock valued at $394,000 after buying an additional 2,959 shares during the period. 82.67% of the stock is currently owned by institutional investors.

AdaptHealth Stock Up 0.8 %

AHCO opened at $10.71 on Friday. AdaptHealth has a twelve month low of $6.91 and a twelve month high of $11.90. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The business has a 50 day moving average price of $9.98 and a 200 day moving average price of $10.38. The firm has a market cap of $1.44 billion, a P/E ratio of -6.49, a price-to-earnings-growth ratio of 1.32 and a beta of 1.09.

AdaptHealth (NASDAQ:AHCO) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.02). AdaptHealth had a positive return on equity of 9.62% and a negative net margin of 6.57%. The firm had revenue of $805.90 million during the quarter, compared to analyst estimates of $809.32 million. During the same quarter in the previous year, the firm posted $0.19 earnings per share. AdaptHealth’s quarterly revenue was up .2% compared to the same quarter last year. Research analysts forecast that AdaptHealth will post 0.88 EPS for the current year.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.